NEW
Allfastra SARS-CoV-2/FluA/FluB/RSV Real Time PCR Kit
Prepare for the COVID-19 pandemic and winter viruses season with a reliable multiplex assay to detect and distinguish 4 viruses.
Monkeypox Virus Diagnostic Solution
With increasing confirmed monkeypox cases, more people, countries, and regions are at risk of infection. Nowadays, confirmed cases of infants and cases in schools have been reported; the monkeypox virus has spread among vulnerable individuals, indicating great urgent demand for early diagnosis. Bioperfectus provides FIVE kits for humans with a CE certificate and ONE kit for veterinary use, presenting a rapid response to help diagnose monkeypox infection as early as possible.
COVID-19 Diagnostic Solution
Although the number of new coronavirus cases fell everywhere in the world, the global pandemic is not over. Bioperfectus continues to provide you with a comprehensive range of products for COVID-19 diagnosis and confirmation, including the antigen rapid tests, antibody rapid test and RT-PCR tests, to safeguard your health.
Cervical Cancer Screening Solution
With over 600 thousand new cases and more than half that would lead to death yearly, cervical cancer is listed as NO.4 cancer among women worldwide. Lack of screening and treatment leads to higher rates of incidence and mortality. Bioperfectus is confident in providing products, supporting tests for cervical swabs, and liquid-based cytology samples with solid results, enabling women to get access to screening and diagnosis at the early stage of HPV infection before the development of precancerous lesions and cervical cancer.
SAW-96
SAW-96 is an automated nucleic acid extraction workstation, which integrates sample loading, nucleic acid purification, and PCR setup functions in one instrument. The run duration is less than 70 minutes for 1-96 samples. Based on experienced magnetic separation technology, SAW-96 provides high throughput automation combined with high performance.
Total PCR Solution
Bioperfectus Total PCR Solution offers holistic products of extraction systems, extraction reagents, real-time PCR systems, and RT-PCR reagents. The automatic solution could help customers to establish a highly efficient PCR workflow and release the labor.

Jiangsu Bioperfectus Technologies Co., Ltd.

(SSE:688399)

Since its founding in 2010, BioPerfectus has been dedicated to providing molecular diagnostic solutions specializing in emerging infectious diseases for generations and generations to come. We are leading the change by offering Real-Time PCR Kits, Nucleic Acid Extraction Systems, Automation Solutions, and Rapid Tests to laboratories, hospitals, institutions, and CDCs across the globe. BioPerfectus products have been distributed to more than 100 countries around the world. As one of the leading global IVD suppliers, BioPerfectus is committed to delivering excellent services and products that meet the highest international quality and safety standards. Our global presence enables us to build close relationships with our clients and leverage our expertise to support them worldwide.

62,000 +㎡

An industrial park of over 62,000㎡ integrating fully self-innovative R&D, production, warehousing, logistics, sales, marketing and customer service divisions catering for various business scenarios

800 +

Over 800 Bioperfectus people’s permission gathering the perseverance and determination to fight against the global pandemic

5,000,000 +

Production capacity ramping up to more than 5 million tests/day ensuring the quick sufficient response to infectious diseases

global presence

90 Countries within a year

Bioperfectus Products & Service have been distributed to over 80+ countries around the globe within only one year since the international business established.

20000 Installation base

Bioperfectus Nucleic Acid Extraction Solutions
were launched in over 20,000 laboratories
globally with a well-trained and quick-response
customer service team.

Product Center
News Center
02-022023
BioPerfectus Received Export Commodity Brand Certificate from the CCPIT
BioPerfectus Received Export Commodity Brand Certificate from the CCPIT
02-022023
BioPerfectus was recently certified as the Export Commodity Brand by the CCPIT (China Council for the Promotion of International Trade). The quality of BioPerfectusmolecular diagnostic products has been officially recognized by the CCPIT. Founded in 1952, CCPIT is a national organization for promoting foreign trade and investment. More than 200 countries and regions worldwide have recognized its legitimacy and validity. Organized by CCPIT, the Export Commodity Brand Certificate is a national endorsement that evaluates the brand from eight dimensions, including RD and innovation capacity, international certification, market recognition, intellectual property protection, globalization, and credit system. Brand competition has become an essential element of competitive power in the global market. As one of the leading global IVD suppliers, BioPerfectus is committed to delivering excellent services and products that meet the highest international quality and safety standards. BioPerfectus products have been distributed to more than 100 countries around the world. Our global presence enables us to build close relationships with our clients and leverage our expertise to support them worldwide, significantly improving the brand's competitiveness in the global market. With the mission of embracing the world with health, we will continue to pursue high quality, keep innovating, and strive to solve health problems faced by mankind for a healthier future.
01-312023
Four New Arrivals for Better Confronting Sexually Transmitted Diseases and Respiratory Infectious Diseases
Four New Arrivals for Better Confronting Sexually Transmitted Diseases and Respiratory Infectious Diseases
01-312023
Infectious diseases are illnesses caused by harmful pathogens that get into your body. The most common causes are viruses, bacteria, fungi and parasites. Because of transmission ways, the number of people infected by sexually transmitted diseases and respiratory infectious diseases is very large. SHANGHAI, CHINA, February 1, 2023Jiangsu Bioperfectus Technologies Co., Ltd. (hereinafter referred to as BioPerfectus) is proud to launchfournew PCR products:Mycoplasma Genitalium Real Time PCR Kit,Herpes Simplex Virus Real Time PCR Kit, Trichomonas Vaginalis Real Time PCR Kit andRespiratory Virus Panel (7) Real Time PCR Kit. Combined with our extraction solution, we could provide a Total PCR Solution for the early detection for sexually transmitted diseases and respiratory diseases which affect many people. AsWHO puts forward the global health strategies for sexually transmitted disease (STD), one of the most significant infectious diseases segmenting and profoundly impacting sexual and reproductive health worldwide, more and more attention has been focused on it. Despitethe prevalence, most STDs have no symptoms and severe consequences beyond the immediate impact of infection, leading to unpleasant results. The BioPerfectus Sexually Transmitted Diseases Total PCR Solution adopts real-time fluorescent PCR technology, intended for the in-vitro qualitative detection of Mycoplasma genitalium virus, herpes simplex virus and Trichomonas Vaginalis specific parasite, providing molecular evidence for early STDs diagnosis and also for high-risk STD population primary screening. Mycoplasma GenitaliumReal Time PCR Kit Mycoplasma Genitalium (M. genitalium) is the smallest known self-replicating bacterium. It is a common cause of nongonococcal urethritis in males and cervicitis in females. If left untreated, M. genitalium infection can lead to adverse outcomes such as ectopic pregnancy and infertility, as well as increasing the risk of HIV transmission and infection. Higher M. genitalium prevalence rates, ranging from 4% to 38%, have been reported among sexually transmitted infection (STI) clinic attendees and cohorts with multiple STI risk factors. Early diagnosis and wide-range screening are crucial linkages in achieving prevention and treatment. Herpes Simplex Virus Real Time PCR Kit Infections with herpes simplex virus (HSV), known as herpes, are common globally. It is a sexually transmitted disease (STD) caused by two types of viruses herpes simplex virus type 1 (HSV-1) and herpes simplex virus type 2 (HSV-2). An estimated 3.7 billion people under the age of 50 (67%) have HSV-1 infection globally. Genital herpes caused by HSV-2 affect an estimated 491 million (13%) people aged 1549 years worldwide. Early diagnosis is of great importance for general screening and proper treatment. Trichomonas Vaginalis Real Time PCR Kit Trichomoniasis is a common and treatable STD caused by infection with Trichomonas vaginalis (TV). Trichomonas vaginalis infection is worldwide distribution, over 170 million people are infected every year. About 70% of people with infection do not have any signs or symptoms. Some people get symptoms within 5 to 28 days after getting the infection. When causing symptoms, they can range from mild irritation to severe inflammation. Pregnant people with this infection are more likely to have their babies early. Also, their babies are more likely to have a low birth weight. Diagnosis is so important for specific groups that it could help prevent from bad influence. Respiratory Virus Panel (7) Real Time PCR Kit Globally, the incident cases of URIs reached 17.2 billion in 2019. Among all age groups, children under five years old suffered from the highest incidence. Upper respiratory tract infections (URIs) are mainly caused by viruses, including rhinovirus, influenza virus, respiratory syncytial virus and so on. The COVID-19 pandemic caused by SARS-CoV-2 further exposed the potential threats of respiratory viruses. URIs are important presentations for the reproduction and circulation of respiratory viruses. Defining most of these patient diseases is difficult because the presentations connected with URIs commonly overlap and their causes are similar. The most common symptoms of URIs include coughing, a sore throat, nasal obstruction, and headache. Although those conditions are often self-limited and non-fatal, in some cases, URIs even induce severe complications, such as pneumonia, otitis media, glomerulonephritis, and myocarditis, thus further adding to the cost of healthcare resources. The Respiratory Virus Panel (7) Real Time PCR Kit developed by BioPerfectus allows for the detection of multiple viruses including Influenza A virus, Influenza B virus, Respiratory syncytial virus, Human rhinovirus, Respiratory adenovirus, Mycoplasma pneumoniae, Parainfluenza virus from human throat swab samples. Dedicated to providing laboratories with comprehensive tests of sexually transmitted diseases and respiratory infectious diseases, BioPerfectus Total PCR Solution brings instruments and reagents. Pioneering in molecular diagnostics, BioPerfectus is always devoted to pursuing high quality, keeping innovating, and striving to solve health problems faced by mankind for a healthier future. Reference: [1] Mustafa M, Illzam E, Muniandy R, et al. Herpes simplex virus infections, Pathophysiology and Management. IOSR Journal of Dental and Medical Sciences, 2016, 15(7):85-91. [2] https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(21)00266-2/fulltext Wenzel RP, Fowler AA. Clinical practice. Acute bronchitis. N Engl J Med. 2006 Nov 16;355(20):2125-30 [3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7223550/#CR2. [4] https://www.who.int/news-room/fact-sheets/detail/sexually-transmitted-infections-(stis)
12-262022
Announcing BioPerfectus New Brand Identity
Announcing BioPerfectus New Brand Identity
12-262022
We are delighted and proud to unveil our new brand identity, which perfectly reflects the evolution of our company since it was established in 2010. After many years of rapid development and transformation, the strong desire for innovation has contributed to this re-branding plan - this is a critical period of transformation.BioPerfectus will start the next "golden decade" with a new attitude and adopt a more international logo in a broader commercial market.We aim to create a stronger image that would build on the previous one and accurately describe who we are today: one of the global IVD suppliers with a mission to embrace the world with health. In 2020, the BioPerfectus International Sales Marketing Division was established, making its official foray into the global market. Since then, BioPerfectus has rapidly expanded its network in the global market and obtained 216 overseas regulatory certificates for market access, including WHO-EUL, FDA-EUA, CE Mark, etc. BioPerfectus products have been distributed to more than 100 countries around the world. As a leading global company in the molecular diagnostics market,BioPerfectus has continuously expanded its breadth and depth of experience as it supports partners worldwide to prevent and control infectious diseases.BioPerfectus, in close collaboration with many governments and non-governmental organizationsworldwide, has built professional and well-trained response teams to ensure readiness for emergency outbreaks in public health.BioPerfectus remains committed to delivering excellent services and products that meet the highest international quality and safety standards. The CEO of BioPerfectus, Dr. Guoqiang Wang, said, This change was inevitable.What changes is the perspective and strength of the company, but what remains unchanged is the original intention. The implied meaning of BioPerfectus represents that life technology makes the world better.The "b" - bio and "p" - perfect highlight the individuality and exclusivity of BioPerfectus, which also implies the company's global vision. The letter combination of "b" and "p" resembles a cell structure that is undergoing replication and division. The "b" is the primitive cell in the primary stage, which is a metaphor for the internal strength and foundation of the enterprise. The "p" is the new cell of differentiation and fission, which means the never-ending entrepreneurial spirit. The two are independent yet complement each other, presenting a dynamic "separation" and "combination, conveying the critical message in a precise and innovative visual manner. The connotation represents inclusiveness, multiculturalism, and embracing outstanding talents for corporate innovation, promoting the growth of the medical industry and protecting human health. We are eager to have a deeper and closer connection with our partners. We have worked closely with our partners to give full play to the advantages and innovation of BioPerfectus, and jointly solve the problems that threaten human survival and life health.The 21st century is the century of life science. "Jointly creating a future without disease" emerges as the ultimate goal of modern medicine and also the commitment of BioPerfectus. In the future, BioPerfectus will continue to improve the brand value and share of voice and other aspects to achieve comprehensive leaps and long-term improvement and initiate the new branding strategy to embrace brilliance actively. The new version of LOGO will be applied to the products, packaging, and dissemination of the belonging series and will gradually come to users in the future.
Service Network
Support is only one step away
A good after-sales service is essential for efficiency of workload in PCR laboratory. Bioperfectus delivers most perfect service via our authorized distributors and global service center. With well-experienced service staff, sufficient spare-part inventory and fast global logistics, Bioperfectus aims to provide with the satisfactory solutions to our end users.We offer 24/7 after-sales service, prompt response and periodical training programs.
CONTACT US NOW